Usp22i-S02

1 1

Selleck Chemicals

E1330-5MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
View full details

Usp22i-S02 is an inhibitor of DUB used in studies of Protein Degradation / Proteasome. In practice, this places the compound in experiments that measure ubiquitin-dependent turnover, proteostasis, and targeted protein degradation in cancer and protein homeostasis models.

By inhibiting DUB, Usp22i-S02 can be used to examine ubiquitin-dependent turnover, proteostasis, and targeted protein degradation. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In cancer and protein homeostasis models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving DUB
  • Pathway perturbation studies connected to Protein Degradation / Proteasome
  • Concentration-response inhibition and target-dependence studies
  • Enzyme-activity assays, substrate-conversion studies, and mechanism profiling

Overall, Usp22i-S02 is appropriate when a defined chemical perturbant is needed to connect DUB with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer and protein homeostasis models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
DUB
Target Class:
Enzyme
Pathways:
Protein Degradation / Proteasome
Research Area:
Cancer • Protein Homeostasis
CAS No.:
309735-96-4
Molecular Weight:
338.41
Formula:
C₂₂H₁₈N₄
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.